Skeletal disproportion in girls with Turner syndrome and longitudinal change with growth-promoting therapy.
Lindsey C McVeyAlexander FletcherMohammed MurtazaMalcolm DonaldsonSze Choong WongAvril MasonPublished in: Clinical endocrinology (2021)
TS is associated with skeletal disproportion, which is more severe in the shortest girls and present in only half of those with milder degrees of short stature. Growth-promoting therapy may improve disproportion during both the childhood and pubertal phases of growth. Change in disproportion status two years after starting rhGH helps predict disproportion at adult height.